glutamine has been researched along with Inborn Urea Cycle Disorder in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 21 (84.00) | 24.3611 |
| 2020's | 4 (16.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burczynski, ME; Chen, H; Cheng, X; Halasz, G; Kim, S; Lin, AZ; Mao, X; Murphy, AJ; Na, E; Okamoto, H; Sleeman, MW | 1 |
| Lichter-Konecki, U; McCarter, R; Sanz, JH | 1 |
| Daniotti, M; Donati, MA; Pochiero, F; Procopio, E; Sacchini, M; Scaturro, G | 1 |
| Aldámiz-Echevarría, L; Almeida Campos, T; Andrade, F; Barba Romero, MA; Blasco, J; Cañedo, E; Ceberio, L; Correcher, P; de Las Heras, J; Del Toro, M; García Silva, MT; García-Jiménez, MC; Gil, D; Marquez, AM; Martín Hernández, E; Peña-Quintana, L; Pintos-Morell, G; Puig-Piña, R; Quijada-Fraile, P; Rodrigues, E; Ruiz-Pons, M; Villate, O; Vitoria, I; Vives-Piñera, I; Yahyaoui, R | 1 |
| Fiumara, A; Iacobacci, R; Meli, C; Messina, M; Raudino, F | 1 |
| Almannai, M; Elsea, SH; Jiang, Y; Sun, Q; Sutton, VR | 1 |
| Berry, SA; Diaz, GA; Ficicioglu, C; Harding, CO; Lichter-Konecki, U; Longo, N; McCandless, SE; Robinson, B; Smith, WE; Vockley, J; Zori, R | 1 |
| Berry, SA; Diaz, GA; Dong, M; Ficicioglu, C; Harding, CO; Holt, RJ; Lichter-Konecki, U; Longo, N; McCandless, SE; Perdok, R; Robinson, B; Smith, WE; Vinks, AA; Vockley, J; Zori, R | 1 |
| Brunetti-Pierri, N; Soria, LR | 1 |
| Berry, SA; Coakley, D; Diaz, GA; Dickinson, K; Lee, B; Lemons, C; Lichter-Konecki, U; Mokhtarani, M; Monteleone, JP; Rhead, W; Scharschmidt, BF | 1 |
| Bartley, J; Berquist, W; Berry, SA; Brown, RS; Coakley, D; Diaz, GA; Dickinson, K; Feigenbaum, A; Gallagher, R; Ghabril, M; Harding, C; Lee, B; Lemons, C; Lichter-Konecki, U; Longo, N; Mantry, P; McCandless, SE; Milikien, DA; Mokhtarani, M; Moors, T; Nagamani, SC; Norris, C; Rhead, W; Rockey, DC; Scharschmidt, BF; Schulze, A; Smith, W; Vierling, JM | 1 |
| Cooper, AJ; Kuhara, T | 1 |
| Berry, SA; Coakley, DF; Diaz, GA; Lee, B; Lemons, C; Lichter-Konecki, U; McCandless, SE; Mokhtarani, M; Nagamani, SC; Rhead, W; Scharschmidt, BF; Smith, W | 1 |
| Bartholomew, D; Bartley, JA; Berquist, W; Berry, SA; Cederbaum, S; Coakley, DF; Diaz, GA; Feigenbaum, A; Gallagher, R; Harding, CO; Korson, MS; Kronn, D; Le Mons, C; Lee, B; Lichter-Konecki, U; Longo, N; Marino, M; McCandless, SE; Merritt, JL; Milikien, DA; Mokhtarani, M; Nagamani, SC; Rhead, W; Scharschmidt, BF; Schulze, A; Smith, W; Summar, M; Vockley, G; Vockley, J; Wong, D; Zori, R | 1 |
| Bartley, J; Berquist, W; Berry, SA; Coakley, DF; Diaz, GA; Feigenbaum, A; Gallagher, RC; Harding, CO; Le Mons, C; Lee, B; Lichter-Konecki, U; Longo, N; Marino, M; McCandless, SE; Mokhtarani, M; Nagamani, SC; Rhead, W; Rowell, R; Scharschmidt, BF; Schulze, A; Smith, W | 1 |
| Aldámiz-Echevarría, L; De Las Heras, J; Delgado, TC; Martínez-Chantar, ML | 1 |
| Arranz, JA; Artuch, R; Briones, P; Campistol, J; Fons, C; García-Cazorla, A; Gómez-López, L; Häberle, J; Jara, F; Martins, C; Murgui, E; Pérez-Dueñas, B; Pineda, M; Serrano, M; Vilaseca, MA | 1 |
| Beliveau, M; Berry, SA; Diaz, GA; Dickinson, K; Gargosky, S; Lee, B; Marier, JF; Martinez, A; Mauney, J; Mian, A; Mokhtarani, M; Rhead, W; Scharschmidt, BF; Shchelochkov, O | 1 |
| Dickinson, K; Gargosky, S; Lowe, ME; Martinez, A; McGuire, BM; Mokhtarani, M; Monteleone, J; Scharschmidt, BF; Syplyviy, VA; Xiao, X; Zupanets, IA | 1 |
| Herebian, D; Laryea, MD; Mayatepek, E; Meissner, T | 1 |
| Artuch, R; Campistol, J; Garcia-Cazorla, A; Garcia-Romero, R; Lambruschini, N; Meavilla, S; Ormazábal, A; Perez-Dueñas, B; Pineda, M; Serrano, M; Vilaseca, MA | 1 |
| Walker, V | 1 |
| Bart, S; Bartholomew, D; Bartley, J; Berquist, W; Berry, SA; Cederbaum, S; Coakley, DF; Diaz, GA; Dickinson, K; Dorrani, N; Feigenbaum, A; Gallagher, R; Harding, CO; Korson, MS; Kronn, D; Lee, B; Lemons, C; Lichter-Konecki, U; Longo, N; McCandless, SE; Merritt, JL; Mokhtarani, M; Moors, TL; Rhead, W; Scharschmidt, BF; Smith, W; Sreenath-Nagamani, S; Summar, M; Vockley, J; Zori, R | 1 |
| Bart, SA; Bartholomew, D; Bartley, J; Berquist, W; Berry, SA; C S Nagamani, S; Cederbaum, S; Coakley, DF; Diaz, GA; Dickinson, K; Feigenbaum, A; Gallagher, R; Harding, CO; Korson, MS; Krivitzky, LS; Kronn, D; Lee, B; Lemons, C; Lichter-Konecki, U; Longo, N; Mauney, J; McCandless, SE; Merritt, JL; Mokhtarani, M; Moors, TL; Rhead, W; Scharschmidt, BF; Smith, W; Vockley, G; Zori, R | 1 |
| Berry, SA; Coakley, DF; Diaz, GA; Dickinson, K; Harding, CO; Lee, B; LeMons, C; Lichter-Konecki, U; Mauney, J; McCandless, SE; Mokhtarani, M; Moors, T; Scharschmidt, BF; Smith, W | 1 |
4 review(s) available for glutamine and Inborn Urea Cycle Disorder
| Article | Year |
|---|---|
Ammonia and autophagy: An emerging relationship with implications for disorders with hyperammonemia.
Topics: Ammonia; Animals; Autophagy; Glutamate-Ammonia Ligase; Glutamine; Homeostasis; Humans; Hyperammonemia; Liver; Urea; Urea Cycle Disorders, Inborn | 2019 |
α-Ketoglutaramate: an overlooked metabolite of glutamine and a biomarker for hepatic encephalopathy and inborn errors of the urea cycle.
Topics: Amidohydrolases; Aminohydrolases; Ammonia; Animals; Biomarkers; Carbon; Glutamine; Hepatic Encephalopathy; Humans; Hyperammonemia; Keto Acids; Ketoglutaric Acids; Kynurenine; Liver Diseases; Mammals; Methionine; Nitrogen; Sulfur; Transaminases; Urea Cycle Disorders, Inborn | 2014 |
An update on the use of benzoate, phenylacetate and phenylbutyrate ammonia scavengers for interrogating and modifying liver nitrogen metabolism and its implications in urea cycle disorders and liver disease.
Topics: Ammonia; Animals; Benzoates; Drug Design; Glutamine; Humans; Liver Cirrhosis; Liver Diseases; Liver Failure, Acute; Nitrogen; Phenylacetates; Phenylbutyrates; Urea Cycle Disorders, Inborn | 2017 |
Severe hyperammonaemia in adults not explained by liver disease.
Topics: Adult; Amino Acids; Ammonia; Biological Transport; Blood-Brain Barrier; Brain; Glutamine; Humans; Hyperammonemia; Liver; Liver Diseases; Nitrogen; Urea; Urea Cycle Disorders, Inborn | 2012 |
7 trial(s) available for glutamine and Inborn Urea Cycle Disorder
| Article | Year |
|---|---|
Glycerol phenylbutyrate treatment in children with urea cycle disorders: pooled analysis of short and long-term ammonia control and outcomes.
Topics: Adolescent; Ammonia; Child; Child, Preschool; Cross-Over Studies; Female; Glutamine; Humans; Infant; Infant, Newborn; Male; Phenylbutyrates; Urea Cycle Disorders, Inborn | 2014 |
Glutamine and hyperammonemic crises in patients with urea cycle disorders.
Topics: Adolescent; Adult; Ammonia; Biomarkers; Child; Child, Preschool; Fasting; Female; Glutamine; Glycerol; Humans; Hyperammonemia; Male; Phenylbutyrates; Predictive Value of Tests; Urea Cycle Disorders, Inborn; Young Adult | 2016 |
Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: safety, pharmacokinetics and ammonia control.
Topics: Adult; Aged; Ammonia; Cross-Over Studies; Female; Glutamine; Glycerol; Humans; Male; Middle Aged; Phenylacetates; Phenylbutyrates; Urea Cycle Disorders, Inborn; Young Adult | 2010 |
Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis.
Topics: Adult; Cross-Over Studies; Female; Glutamine; Humans; Hydrolysis; Lipase; Liver Cirrhosis; Male; Monte Carlo Method; Phenylbutyrates; Urea Cycle Disorders, Inborn | 2010 |
Urinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disorders.
Topics: Adolescent; Adult; Ammonia; Biomarkers, Pharmacological; Child; Cross-Over Studies; Drug Administration Schedule; Female; Glutamine; Glycerol; Humans; Male; Phenylacetates; Phenylbutyrates; Urea Cycle Disorders, Inborn | 2012 |
Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate.
Topics: Adolescent; Adult; Ammonia; Child; Cross-Over Studies; Double-Blind Method; Female; Glutamine; Glycerol; Humans; Male; Middle Aged; Neuropsychological Tests; Phenylbutyrates; Urea Cycle Disorders, Inborn; Young Adult | 2013 |
Ammonia control in children ages 2 months through 5 years with urea cycle disorders: comparison of sodium phenylbutyrate and glycerol phenylbutyrate.
Topics: Ammonia; Child; Child, Preschool; Drug Substitution; Female; Glutamine; Glycerol; Humans; Infant; Liver; Male; Phenylbutyrates; Surveys and Questionnaires; Urea Cycle Disorders, Inborn | 2013 |
14 other study(ies) available for glutamine and Inborn Urea Cycle Disorder
| Article | Year |
|---|---|
Glutaminase 2 knockdown reduces hyperammonemia and associated lethality of urea cycle disorder mouse model.
Topics: Ammonia; Animals; Disease Models, Animal; Glutaminase; Glutamine; Humans; Hyperammonemia; Liver; Mice; Ornithine Carbamoyltransferase; Ornithine Carbamoyltransferase Deficiency Disease; Urea; Urea Cycle Disorders, Inborn | 2022 |
Relationship between longitudinal changes in neuropsychological outcome and disease biomarkers in urea cycle disorders.
Topics: Ammonia; Biomarkers; Glutamine; Humans; Hyperammonemia; Longitudinal Studies; Neuropsychological Tests; Urea Cycle Disorders, Inborn | 2023 |
Transition to glycerol phenylbutyrate for the management of urea cycle disorders: clinical experiences.
Topics: Ammonia; Glutamine; Humans; Quality of Life; Urea; Urea Cycle Disorders, Inborn | 2023 |
Quantification of urinary derivatives of Phenylbutyric and Benzoic acids by LC-MS/MS as treatment compliance biomarkers in Urea Cycle disorders.
Topics: Adolescent; Adult; Benzoates; Biomarkers; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Glutamine; Humans; Infant; Infant, Newborn; Male; Medication Adherence; Phenylbutyrates; Tandem Mass Spectrometry; Urea Cycle Disorders, Inborn; Young Adult | 2019 |
New ratio as a useful marker for early diagnosis of proximal urea cycle disorders.
Topics: Biomarkers; Citrulline; Early Diagnosis; Glutamine; Humans; Infant, Newborn; Urea Cycle Disorders, Inborn | 2021 |
Quantitation of phenylbutyrate metabolites by UPLC-MS/MS demonstrates inverse correlation of phenylacetate:phenylacetylglutamine ratio with plasma glutamine levels.
Topics: Ammonia; Argininosuccinic Aciduria; Chromatography, Liquid; Female; Glutamine; Glycerol; Humans; Limit of Detection; Male; Middle Aged; Ornithine Carbamoyltransferase Deficiency Disease; Phenylacetates; Phenylbutyrates; Tandem Mass Spectrometry; Urea; Urea Cycle Disorders, Inborn | 2017 |
Safety and efficacy of glycerol phenylbutyrate for management of urea cycle disorders in patients aged 2months to 2years.
Topics: Ammonia; Child, Preschool; Cough; Disease Management; Drug-Related Side Effects and Adverse Reactions; Female; Fever; Glutamine; Glycerol; Humans; Infant; Male; Neutropenia; Phenylbutyrates; Prospective Studies; Retrospective Studies; Urea Cycle Disorders, Inborn | 2017 |
Pharmacokinetics of glycerol phenylbutyrate in pediatric patients 2 months to 2 years of age with urea cycle disorders.
Topics: Child; Child, Preschool; Female; Glutamine; Glycerol; Humans; Infant; Lipase; Male; Nitrogen; Phenylacetates; Phenylbutyrates; Prodrugs; Urea Cycle Disorders, Inborn | 2018 |
Population pharmacokinetic modeling and dosing simulations of nitrogen-scavenging compounds: disposition of glycerol phenylbutyrate and sodium phenylbutyrate in adult and pediatric patients with urea cycle disorders.
Topics: Adult; Child; Child, Preschool; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Computer Simulation; Female; Glutamine; Glycerol; Humans; Male; Models, Biological; Nitrogen; Phenylbutyrates; Randomized Controlled Trials as Topic; Rare Diseases; Urea Cycle Disorders, Inborn | 2013 |
Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio.
Topics: Biomarkers; Drug-Related Side Effects and Adverse Reactions; Glutamine; Glycerol; Hepatic Encephalopathy; Humans; Liver; Neoplasms; Phenylacetates; Phenylbutyrates; Randomized Controlled Trials as Topic; Urea Cycle Disorders, Inborn | 2013 |
Blood ammonia and glutamine as predictors of hyperammonemic crises in patients with urea cycle disorder.
Topics: Adolescent; Adult; Ammonia; Child; Child, Preschool; Female; Glutamine; Humans; Hyperammonemia; Infant; Male; Middle Aged; Predictive Value of Tests; Urea Cycle Disorders, Inborn; Young Adult | 2015 |
Neuropsychiatric manifestations in late-onset urea cycle disorder patients.
Topics: Adolescent; Adult; Age of Onset; Carbamoyl-Phosphate Synthase I Deficiency Disease; Child; Child, Preschool; Citrullinemia; Female; Follow-Up Studies; Glutamine; Humans; Male; Mental Disorders; Ornithine Carbamoyltransferase Deficiency Disease; Quaternary Ammonium Compounds; Retrospective Studies; Treatment Outcome; Urea Cycle Disorders, Inborn | 2010 |
Simultaneous LC-MS/MS determination of phenylbutyrate, phenylacetate benzoate and their corresponding metabolites phenylacetylglutamine and hippurate in blood and urine.
Topics: Benzoates; Biomarkers; Biotransformation; Calibration; Chromatography, Reverse-Phase; Glutamine; Hippurates; Humans; Hyperammonemia; Limit of Detection; Linear Models; Phenylacetates; Phenylbutyrates; Predictive Value of Tests; Reference Standards; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Urea Cycle Disorders, Inborn | 2010 |
Assessment of plasma ammonia and glutamine concentrations in urea cycle disorders.
Topics: Ammonia; Glutamine; Humans; Infant, Newborn; Urea Cycle Disorders, Inborn | 2011 |